Fluorescence biodistribution and photosensitising activity of toluidine blue o on rat buccal mucosa.
The antimicrobial activity of toluidine blue O (TBO) in the presence of red light has been demonstrated for a wide range of microorganisms. The response of tissues to TBO-induced photosensitisation is an important factor in assessing the clinical usefulness of this technique for the treatment of infectious diseases. The aims of this study were to determine the effect of TBO-mediated photosensitisation on rat buccal mucosa and the biodistribution of the photosensitiser in this tissue. An aqueous solution of TBO was applied to one side of the buccal mucosa of the animals. A 6 mm diameter area was then exposed to light (633 nm) from a copper vapour pumped-dye laser. The opposite, untreated, side of the buccal mucosa served as a control. TBO concentrations of 25, 50 and 200 microg/ml, laser light doses of 110, 170 and 340 J/cm(2) were assessed. Control groups of animals were subjected to 340 J/cm(2) laser light alone or to 200 microg/ml TBO alone. Serial sacrifices were performed after 72 h to obtain mucosal tissue samples for histological examination. For the determination of TBO biodistribution, additional groups received the same TBO doses and were sacrificed after 1 min or 10 min. Specimens were removed and frozen immediately for digital fluorescence imaging. No necrotic or inflammatory changes were found in the buccal mucosa of the animals with any of the treatments (using up to 200 microg/ml TBO and 340 J/cm(2) laser light). A high TBO fluorescence in the epithelium, particularly in the keratinised layer, with almost no fluorescence in the underlying connective tissue was demonstrated by the digital imaging. The results of this study suggest that TBO-mediated PDT (within the concentrations and light doses tested) could be a safe antimicrobial approach for the oral infections without damaging the adjacent normal tissue.
Kömerik
N
N
Department of Microbiology, Oral Maxilofacial Surgery, Eastman Dental Institute for Oral Health Care Sciences, University College London, UK.
Curnow
A
A
MacRobert
A J
AJ
Hopper
C
C
Speight
P M
PM
Wilson
M
M
D000818:Animals; D005260:Female; D009061:Mouth Mucosa / Q000187:drug effects*; D017319:Photosensitizing Agents / Q000009:adverse effects* / Q000493:pharmacokinetics; D051381:Rats; D017208:Rats, Wistar; D014048:Tolonium Chloride / Q000009:adverse effects* / Q000493:pharmacokinetics
D017319:Photosensitizing Agents; D014048:Tolonium Chloride